Evidence map›Paper›PMID 36295830›Full record

ArticleMetabolites2022

Substantial Fat Loss in Physique Competitors Is Characterized by Increased Levels of Bile Acids, Very-Long Chain Fatty Acids, and Oxylipins.

Heikki V Sarin, Juha J Hulmi, Youwen Qin, Michael Inouye, Scott C Ritchie, Susan Cheng, Jeramie D Watrous, Thien-Tu C Nguyen, Joseph H Lee, Zhezhen Jin and 10 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Heikki V SarinTHL-Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
Juha J HulmiNeuromuscular Research Center, Faculty of Sport and Health Sciences, University of Jyväskylä, FI-40014 Jyväskylä, Finland.ORCID 0000-0003-3813-2124
Youwen QinCambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Michael InouyeCambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Scott C RitchieCambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Susan ChengDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Jeramie D WatrousDepartments of Medicine and Pharmacology, University of California, San Diego, CA 92093, USA.
Thien-Tu C NguyenDepartments of Medicine and Pharmacology, University of California, San Diego, CA 92093, USA.ORCID 0000-0002-9298-016X
Joseph H LeeSergievsky Center, Taub Institute and Departments of Epidemiology and Neurology, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-2000-4821
Zhezhen JinDepartment of Biostatistics, Mailman School of Public Health Columbia University, New York, NY 10032, USA.
Joseph D TerwilligerTHL-Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
Teemu NiiranenTHL-Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
Aki HavulinnaTHL-Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
Veikko SalomaaTHL-Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
Kirsi H PietiläinenObesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
Ville IsolaNeuromuscular Research Center, Faculty of Sport and Health Sciences, University of Jyväskylä, FI-40014 Jyväskylä, Finland.
Juha P AhtiainenNeuromuscular Research Center, Faculty of Sport and Health Sciences, University of Jyväskylä, FI-40014 Jyväskylä, Finland.
Keijo HäkkinenNeuromuscular Research Center, Faculty of Sport and Health Sciences, University of Jyväskylä, FI-40014 Jyväskylä, Finland.
Mohit JainDepartments of Medicine and Pharmacology, University of California, San Diego, CA 92093, USA.
Markus PerolaTHL-Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
University of Jyväskylä · FIBaker Heart and Diabetes Institute · AUUniversity of California San Diego · USUniversity of Helsinki · FIColumbia University · USFinnish Institute for Health and Welfare · FICedars-Sinai Medical Center · USNew York Psychoanalytic Society and Institute · USUniversity of Turku · FI

Funding

Academy of Finland 269517, 275922, 35443, 314383, 272376, 266286, 321356Finnish Diabetes Research FoundationFinnish Foundation for Cardiovascular ResearchFinnish Medical FoundationGyllenberg FoundationHelsinki University Hospital Government Research FundsNational Institute for Health Research (NIHR) Cambridge Biomedical Research Centre BRC-1215-20014Novo Nordisk Foundation NNF20OC0060547, NNF17OC0027232, NNF10OC1013354The Finnish Medical FoundationThe US National Institutes of Health K01DK116917, S10OD020025, R01ES027595, R01HL143227University of Helsinki
6 · The paper itself

Abstract

Weight loss and increased physical activity may promote beneficial modulation of the metabolome, but limited evidence exists about how very low-level weight loss affects the metabolome in previously non-obese active individuals. Following a weight loss period (21.1 ± 3.1 weeks) leading to substantial fat mass loss of 52% (−7.9 ± 1.5 kg) and low body fat (12.7 ± 4.1%), the liquid chromatography-mass spectrometry-based metabolic signature of 24 previously young, healthy, and normal weight female physique athletes was investigated. We observed uniform increases (FDR < 0.05) in bile acids, very-long-chain free fatty acids (FFA), and oxylipins, together with reductions in unsaturated FFAs after weight loss. These widespread changes, especially in the bile acid profile, were most strongly explained (FDR < 0.05) by changes in android (visceral) fat mass. The reported changes did not persist, as all of them were reversed after the subsequent voluntary weight regain period (18.4 ± 2.9 weeks) and were unchanged in non-dieting controls (n = 16). Overall, we suggest that the reported changes in FFA, bile acid, and oxylipin profiles reflect metabolic adaptation to very low levels of fat mass after prolonged periods of intense exercise and low-energy availability. However, the effects of the aforementioned metabolome subclass alteration on metabolic homeostasis remain controversial, and more studies are warranted to unravel the complex physiology and potentially associated health implications. In the end, our study reinforced the view that transient weight loss seems to have little to no long-lasting molecular and physiological effects.

Indexed as

bioactive metabolitesexerciseLC-MS metabolomevisceral fat massweight loss

Identifiers

PMID36295830
PMCPMC9609491
OpenAlexW4303857008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.